Calmare Therapeutics Inc (fka CTTC)

[Vaffan-Coulo]

"...trivial negative things..."???

Trivial? You find it "trivial" that the authors' data in NO WAY resembles the data Starkweather presented for presumably the same group of patients she presented last year at a nursing meeting:

how VERY strange

Even MORE ODD is that the data presented at that meeting suggested the calmare wasn't JUST a pain reliever, it was a MIRACULOUS pain reliever that ALSO relieved allodynia and reduced opiate consumption by FIFTY PER CENT!!!

WHY didn't the authors use THAT data? It certainly is a LOT more impressive than the data they chose to present! WHY didn't they mention allodynia? WHY didn't they mention opiate reduction?

Could it be that if they thought that if they tried to get away with using the nursing meeting data, someone might "call them on the carpet," so to speak?

In any case, I wrote to the sof the journal to see if they could find out why the data already published in abstract form was so radically different in this latest "incarnation." I'll let you know if they find out anything.